Company / Operating Income
Veracyte, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$57.8M
FY2025
5-year range
-$85.8M / $57.8M
FY2021-FY2025
Trend
+257.9%
vs FY2024
Sector context
#81 of 151
Health Care
What the data says
Operating Income changed +258% YoY in FY2025, a notable deviation from the 9-year average annual change of +12%.
Based on SEC 10-K filings.
$58M in FY2025.
Improved from -$86M to $58M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 151 in Health CareTop 54% of 151This company $57.8M Sector average $716.7M
▼
-91.9% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 257.9% year-over-year.
- Ranks #81 out of 151 companies in the Health Care sector.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.8M | +257.9% |
| FY2024 | $16.1M | +118.8% |
| FY2023 | -$85.8M | -108.8% |
| FY2022 | -$41.1M | +49.8% |
| FY2021 | -$81.9M | -131.4% |
| FY2020 | -$35.4M | -133.9% |
| FY2019 | -$15.1M | +32.0% |
| FY2018 | -$22.2M | +16.2% |
| FY2017 | -$26.5M | +7.9% |
| FY2016 | -$28.8M | +13.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026